Single‐cell transcriptomics reveal metastatic CLDN4 + cancer cells underlying the recurrence of malignant pleural effusion in patients with advanced non‐small‐cell lung cancer
Clinical and Translational Medicine · 2024
DOI: 10.1002/ctm2.1649 ↗Kurz gefasst
Fachartikel in der Zeitschrift Clinical and Translational Medicine, 2024. Verfasst von Xiaoshen Zhang und 5 weiteren Autor:innen. Beteiligte Einrichtung: School of Medicine, Tongji University, Shanghai, China. Hauptthemen laut MEDLINE: Carcinoma, Non-Small-Cell Lung, Pleural Effusion, Malignant, Lung Neoplasms. Die Arbeit wurde bisher 10-mal zitiert (Crossref) und nennt 69 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Shanghai Key Clinical Specialty Construction Project-Respiratory Medicine, National Key Clinical Program on Oncology.
Abstract (Originalsprache)
Background
Recurrent malignant pleural effusion (MPE) resulting from non‐small‐cell lung cancer (NSCLC) is easily refractory to conventional therapeutics and lacks predictive markers. The cellular or genetic signatures of recurrent MPE still remain largely uncertain.
Methods
16 NSCLC patients with pleural effusions were recruited, followed by corresponding treatments based on primary tumours. Non‐recurrent or recurrent MPE was determined after 3–6 weeks of treatments. The status of MPE was verified by computer tomography (CT) and cytopathology, and the baseline pleural fluids were collected for single‐cell RNA sequencing (scRNA‐seq). Samples were then integrated and profiled. Cellular communications and trajectories were inferred by bioinformatic algorithms. Comparative analysis was conducted and the results were further validated by quantitative polymerase chain reaction (qPCR) in a larger MPE cohort from the authors' centre ( n = 64).
Results
The scRNA‐seq revealed that 33 590 cells were annotated as 7 major cell types and further characterized into 14 cell clusters precisely. The cell cluster C1, classified as Epithelial Cell Adhesion Molecule ( EpCAM )+ metastatic cancer cell and correlated with activation of tight junction and adherence junction, was significantly enriched in the recurrent MPE group, in which Claudin‐4 ( CLDN4 ) was identified. The subset cell cluster C3 of C1, which was enriched in recurrent MPE and demonstrated a phenotype of ameboidal‐type cell migration, also showed a markedly higher expression of CLDN4 . Meanwhile, the expression of CLDN4 was positively correlated with E74 Like ETS Transcription Factor 3 ( ELF3 ), EpCAM and Tumour Associated Calcium Signal Transducer 2 ( TACSTD2 ), independent of driver‐gene status. CLDN4 was also found to be associated with the expression of Hypoxia Inducible Factor 1 Subunit Alpha ( HIF1A ) and Vascular Endothelial Growth Factor A ( VEGFA ), and the cell cluster C1 was the major mediator in cellular communication of VEGFA signalling. In the extensive MPE cohort, a notably increased expression of CLDN4 in cells from pleural effusion among patients diagnosed with recurrent MPE was observed, compared with the non‐recurrent group, which was also associated with a trend towards worse overall survival (OS).
Conclusions
CLDN4 could be considered as a predictive marker of recurrent MPE among patients with advanced NSCLC. Further validation for its clinical value in cohorts with larger sample size and in‐depth mechanism studies on its biological function are warranted.
Trial registration
Not applicable.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- School of Medicine, Tongji University, Shanghai, China.
- Department of Medical Oncology, Shanghai Pulmonary Hospital, Tongji University School of Medicine, Shanghai, China.
ORCID-Profile: Caicun Zhou
Förderung
- Shanghai Key Clinical Specialty Construction Project-Respiratory Medicine
- National Key Clinical Program on Oncology
Zitieren
APA
Zhang, X., Wang, X., Wen, Y., Chen, S., Zhou, C., & Wu, F. (2024). Single‐cell transcriptomics reveal metastatic CLDN4 + cancer cells underlying the recurrence of malignant pleural effusion in patients with advanced non‐small‐cell lung cancer. Clinical and Translational Medicine. https://doi.org/10.1002/ctm2.1649
Vancouver
Zhang X, Wang X, Wen Y, Chen S, Zhou C, Wu F. Single‐cell transcriptomics reveal metastatic CLDN4 + cancer cells underlying the recurrence of malignant pleural effusion in patients with advanced non‐small‐cell lung cancer. Clinical and Translational Medicine. 2024. doi:10.1002/ctm2.1649
BibTeX
@article{Zhang2024,
author = {Zhang, Xiaoshen and Wang, Xuanhe and Wen, Yaokai and Chen, Shen and Zhou, Caicun and Wu, Fengying},
title = {Single‐cell transcriptomics reveal metastatic CLDN4 + cancer cells underlying the recurrence of malignant pleural effusion in patients with advanced non‐small‐cell lung cancer},
journal = {Clinical and Translational Medicine},
year = {2024},
doi = {10.1002/ctm2.1649}
}
EUVIMED